| Date Filed | Type | Description |
| 08/02/2022 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
| 08/01/2022 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 08/01/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/28/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/15/2022 |
8-K
| Quarterly results |
| 07/11/2022 |
SC 13G
| STATE STREET CORP reports a 11.2% stake in INITIAL FILING PRAXIS PRECISION MEDICINES INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 5.9% stake in AMENDED FILING DECIPHERA PHARMACEUTICALS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 0.6% stake in EXIT FILING DERMTECH INC |
| 07/11/2022 |
SC 13G
| STATE STREET CORP reports a 11.4% stake in INITIAL FILING PMV PHARMACEUTICALS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 11.5% stake in AMENDED FILING EDITAS MEDICINE INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 0.3% stake in EXIT FILING G1 THERAPEUTICS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 13.9% stake in AMENDED FILING PROTAGONIST THERAPEUTICS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 13.9% stake in AMENDED FILING RIGEL PHARMACEUTICALS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 2.6% stake in EXIT FILING BLUEBIRD BIO INC |
| 07/11/2022 |
SC 13G
| STATE STREET CORP reports a 10.2% stake in INITIAL FILING SORRENTO THERAPEUTICS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 12% stake in AMENDED FILING ALTO INGREDIENTS INC |
| 07/11/2022 |
SC 13G/A
| STATE STREET CORP reports a 10% stake in AMENDED FILING BLACK HILLS CORP |
| 06/28/2022 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 06/16/2022 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/13/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/23/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
4
| SUMME GREGORY L (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| SERGEL RICHARD P (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| Rhea John B (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 4,406 shares
@ $0 |
|
| 05/20/2022 |
4
| Portalatin Julio A (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| O'Sullivan Sean (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| Meaney William L (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| MATHEW SARA (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| Freda William C (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| Fawcett Amelia C. (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| DeMaio Donna (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| de Saint-Aignan Patrick (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 05/20/2022 |
4
| Chandoha Marie A (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 2,912 shares
@ $0 |
|
|